Golub Capital Ate Its Three Credits, Then Waived the Fee
A 2.3% adjusted ROE quarter, a $0.25 hit from three names, and the first honest rate regime change in two years — while the stock slides into the print.
GBDC · Earnings Call · 2026-11-18
Three names, not a wave
David Golub opened with the least defensible sentence a BDC CEO can utter and then defended it well: “The headline is that we're disappointed with GBDC's quarter.” — David B. Golub, Chief Executive Officer · 2026-11-18 Adjusted net investment income was $0.33 per share (9.4% adjusted NII ROE), but $0.25 per share of net unrealized and realized losses dragged adjusted EPS to $0.08 and the adjusted ROE to 2.3%. NAV went from $14.25 to $14.00. About $0.21 of the hit came from marking debt and equity in companies already on nonaccrual; roughly $0.04 from equity in previously restructured names. “Almost all the loss related to fair value changes on 3 investments that we previously identified as problem credits.” — David B. Golub, Chief Executive Officer · 2026-11-18 The concentration is the argument. Nonaccruals fell slightly to 1.6% of the portfolio at fair value across 22 names; 85%-plus of the $7.8 billion, 432-borrower book still sits in the top two internal ratings. The problem credits were known, not new — and Golub was explicit that this is the credit stress regime he has been calling for a year. The tell is that the 12.2% in rating-3 loans rose mostly because 4s and 5s got repaid, not because credits migrated: “we're not seeing migration. We're not seeing emergence of a bunch of new problems.” — David B. Golub, Chief Executive Officer · 2026-11-18 The fundamentals tape, which still reflects the June quarter (filed August 3), shows how much room the mark-to-market has to swing earnings: net income of $57 million, down 37% year over year, versus a $94 million peak in 2025Q3 and a 54% drawdown from it. This is a business whose reported earnings are hostage to a handful of marks.The fee waiver is a sequel, not a reveal
Golub's alignment gesture: “we've elected to waive the entirety of GBDC's income incentive fee for the quarter ended December 31, 2026.” — David B. Golub, Chief Executive Officer · 2026-11-18 Note the precedent. Income incentive fee waivers were the single hottest company keyword back in 20241, and equity investment proceeds and net unrealized swings have been recurring furniture in this transcript for years. What's different is the timing: the last waiver cycle accompanied a merger and fee-structure reset; this one accompanies a NAV dent. Management is paying shareholders for the bumpiness it predicted. Capital allocation reads as patient, not panicked. GBDC bought back 793,000 shares at a $12.75 weighted average, an 11% discount to June 30 NAV, and affiliates now hold about 9% of shares. But look at the scale: repurchases of $14 million in the June quarter, versus a $36 million peak. With effective net cash of -$4.5 billion and liabilities at 55.6% of assets, this is a balance sheet that can buy back or lend, but not both at scale. Golub said it plainly: “We're now in an environment where both are attractive. We're going to have to find the right balance.” — David B. Golub, Chief Executive Officer · 2026-11-18The rate regime actually flipped
This is the most underappreciated item on the call. The global keyword board this quarter is dominated by hikes — a Fed rate hike sits near the very top of the market's editorial ranking, alongside related rate-increase language — and GBDC's own vocabulary flipped with it. In 20261 the company's keyword list carried «lower base rates» in the top three, framed as a headwind to earnings power. This quarter Base rates ranks third again, but with the sign reversed: “Base rates are going up, spreads have improved, documentation terms and leverage have become more lender-friendly.” — David B. Golub, Chief Executive Officer · 2026-11-18 The sensitivity is mechanical and large for a ~100% floating-rate book: “every 50 basis point increase in base rates will result in over $0.01 per share of incremental earnings per quarter” — Christopher Ericson, Chief Financial Officer · 2026-11-18, and the September hike isn't even in the 9.9% investment income yield yet because of the timing of contractual rate resets. Borrowing costs ticked to 5.6% after the 2.5% notes matured, and the net spread compressed modestly to 4.3% — but the forward direction is now helper, not hindrance.What management stopped saying — and what they started
The fade is real. AI risk was the company's number one keyword in 20261; AI disruption risk ranked third in 20262, and Golub quantified it: “roughly 2% of our overall portfolio is in a category of elevated AI risk” — David B. Golub, Chief Executive Officer · 2026-05-05. This quarter, software slides to the back half of the keyword board and gets one Q&A answer — “AI is going to create winners and losers in software” — David B. Golub, Chief Executive Officer · 2026-11-18 — plus the observation that client IT budgets are stressed by paying for tokens, stretching sales cycles. Not a repudiation, but a demotion. When 27% of the book is software, going quiet on the risk frame is worth marking. What's newly loud: Maturity extensions and amendment activity, which management now presents as a value lever — repricing strong credits and extracting sponsor support from weak ones. And the state-of-the-cycle call:That junior debt warning is the cleanest forward-looking claim on the call — a structural call that the coming losses sit beneath Golub's first-lien stack, not in it. The proof case offered was U.S. Dermatology Partners, a 2016 vintage that went through forbearance in 2019, a debt-for-equity conversion, a multiyear rebuild, and this August a combination with DermCare that returned full principal, all accrued interest, and equity proceeds. Company-unique, top-ranked, and the only hard evidence in the deck that the workout bench (about 20 professionals) actually monetizes.My expectation is that higher-than-normal credit stress... it's going to continue as an industry-wide headwind for the next several quarters. In addition, I think you're going to start to see more and more discussion about junior debt investments, of which we have relatively little.
The bet, stated plainly
The swing factor is mark reversal: “there's approximately $0.29 per share in net asset value upside associated with debt investments in rating categories 4 and 5” — David B. Golub, Chief Executive Officer · 2026-11-18 — more than a full quarter's loss, and two quarters of NAV damage, sitting in rating categories 4 and 5 on loans that are mostly performing. If that reverses, this becomes a washed-out quarter with a fee waiver attached. That is the entire bull case, and it rests on the same judgment that produced the $0.25 hit. Which is why the prior call matters. In August, Golub said:That was an early identification claim, made with a confidence the September marks just bruised. He has hedged the frame before — “It's harder for us to produce the ROEs that we want to be producing in the current environment than it's been in recent years” — David B. Golub, Chief Executive Officer · 2026-02-05 — and the market has been voting against him: GBDC is down 8.4% over 90 trading days, 9.5% off its August 13 high, and roughly 41% below its 2017 peak, even as the stock trades at a wide discount to NAV. Price to net income has re-rated to 19.5x, up 88% year over year. The read-through: credit stress is not company-unique — Reserve strengthening rings through the market's own Q4 keyword board — but Golub's version is unusually name-concentrated and unusually well-admitted. A floating-rate lender entering a hike cycle with 5.3-year debt maturities against 3-year assets, a 1.17x leverage ratio, 1.6% nonaccruals, and a $0.29 reversal chip on the table is a fund that wants to be judged in twelve months, not today.I think we're most of the way towards having identified the credits in our portfolio that are going to have challenges.